2024
Hand2 Immunohistochemistry in the Diagnosis of Paragangliomas and Other Neuroendocrine Neoplasms
SOUKUP, Jiri, Monika MANETHOVA, Vaclav STEJSKAL, Marie NOVAKOVA, Jaroslava DUSKOVA et. al.Základní údaje
Originální název
Hand2 Immunohistochemistry in the Diagnosis of Paragangliomas and Other Neuroendocrine Neoplasms
Autoři
SOUKUP, Jiri (203 Česká republika), Monika MANETHOVA (203 Česká republika), Vaclav STEJSKAL (203 Česká republika), Marie NOVAKOVA (203 Česká republika), Jaroslava DUSKOVA (203 Česká republika), Helena HORNYCHOVA (203 Česká republika), Maria HACOVA (203 Česká republika), Iva STANICZKOVÁ ZAMBO (203 Česká republika, domácí), Tomas ZELINKA (203 Česká republika), Mikulas KOSAK (203 Česká republika), Tomas CESAK (203 Česká republika), David NETUKA (203 Česká republika), Ales RYSKA (203 Česká republika) a Filip GABALEC (203 Česká republika)
Vydání
Endocrine Pathology, Totowa, Humana Press INC, 2024, 1046-3976
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30109 Pathology
Stát vydavatele
Spojené státy
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 4.400 v roce 2022
Organizační jednotka
Lékařská fakulta
UT WoS
001173128600001
Klíčová slova anglicky
Hand2; dHand; Paraganglioma; Phox2B; GATA3; Neuroendocrine tumors
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 3. 5. 2024 14:46, Mgr. Tereza Miškechová
Anotace
V originále
Hand2 is a core transcription factor responsible for chromaffin cell differentiation. However, its potential utility in surgical pathology has not been studied. Thus, we aimed to investigate its expression in paragangliomas, other neuroendocrine neoplasms (NENs), and additional non-neuroendocrine tumors. We calibrated Hand2 immunohistochemistry on adrenal medulla cells and analyzed H-scores in 46 paragangliomas (PGs), 9 metastatic PGs, 21 cauda equina neuroendocrine tumors (CENETs), 48 neuroendocrine carcinomas (NECs), 8 olfactory neuroblastomas (ONBs), 110 well-differentiated NETs (WDNETs), 10 adrenal cortical carcinomas, 29 adrenal cortical adenomas, 8 melanomas, 41 different carcinomas, and 10 gastrointestinal stromal tumors (GISTs). Both tissue microarrays (TMAs) and whole sections (WSs) were studied. In 171 NENs, previously published data on Phox2B and GATA3 were correlated with Hand2. Hand2 was positive in 98.1% (54/55) PGs, but only rarely in WDNETs (9.6%, 10/104), CENETs (9.5%, 2/21), NECs (4.2%, 2/48), or ONBs (12.5%, 1/8). Any Hand2 positivity was 98.1% sensitive and 91.7% specific for the diagnosis of PG. The Hand2 H-score was significantly higher in primary PGs compared to Hand2-positive WDNETs (median 166.3 vs. 7.5; p < 0.0001). Metastatic PGs were positive in 88.9% (8/9). No Hand2 positivity was observed in any adrenal cortical neoplasm or other non-neuroendocrine tumors, with exception of 8/10 GISTs. Parasympathetic PGs showed a higher Hand2 H-score compared to sympathetic PGs (median H-scores 280 vs. 104, p < 0.0001). Hand2 positivity in NENs serves as a reliable marker of primary and metastatic PG, since other NENs only rarely exhibit limited Hand2 positivity.
Návaznosti
LM2023033, projekt VaV |
|